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Abstract: A multimodal endomicroscope was developed for cancer detection that combines 
hyperspectral and confocal imaging through a single foveated objective and a vibrating 
optical fiber bundle. Standard clinical examination has a limited ability to identify early stage 
oral cancer. Optical detection methods are typically restricted by either achievable resolution 
or a small field-of-view. By combining high resolution and widefield spectral imaging into a 
single probe, a device was developed that provides spectral and spatial information over a 5 
mm field to locate suspicious lesions that can then be inspected in high resolution mode. The 
device was evaluated on ex vivo biopsies of human oral tumors. 
©2017 Optical Society of America 
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(170.3890) Medical optics instrumentation; (170.1790) Confocal microscopy. 
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1. Introduction 
Early detection of oral squamous cell carcinoma (SCC), the most common type of head and 
neck cancer, is critical to improve patient outcomes. It is estimated that there will be over 
48,000 new cases of oral cancer in the United States, with nearly 10,000 deaths predicted in 
2016 alone [1]. Although the oral cavity is simple to access and inspect for frequent 
screening, cancers are often discovered at a late stage when treatment options are more 
invasive and less effective. While the five year survival rate of localized oral cancers is 
around 80%, survival rates drop below 40% for oral cancers diagnosed at a more advanced 
stage [1]. Although oral examination should be trivial due to the ease of access of the orifice, 
around 65% of oral cancers are detected at a later stage, when treatment options become more 
limited [2]. Early detection of oral cancer is facilitated by clinical oral examination (COE), 
where a trained physician performs visual inspection and palpation of the head and neck 
regions to evaluate the oral mucosa for abnormal changes such as leukoplakia and 
erythroplakia; biopsy is required to confirm the presence of disease [2,3]. Pathologic 
assessment of biopsies allow for precise identification of the presence and grade of neoplastic 
disease including mild, moderate, or severe dysplasia or the presence of invasive carcinoma 
[4]. The recognition of oral carcinoma is highly dependent on the skill and experience of the 
clinician [2]. In an effort to improve upon the sensitivity and specificity of COE, several 
imaging techniques have been developed to improve the contrast between early neoplastic 
lesions and surrounding normal or benign tissue, with the goal of improving early detection 
while reducing the time and cost to obtain unnecessary biopsies. 
One particularly simple and well-implemented optical technique is widefield 
autofluorescence imaging. Normal oral mucosa emits blue-green fluorescence (primarily due 
to stromal collagen) when excited by UV or blue light [5]. Neoplasia is associated with a loss 
of blue-green autofluorescence and increased red fluorescence [6] attributed to degradation of 
fluorescent crosslinks in stromal collagen, an increase in vascularity, and an increase in 
epithelial scattering [7–9]. Ideally, the loss of fluorescence can be used to quickly identify 
neoplastic regions and tumor margins. Unfortunately, stromal inflammation and other benign 
lesions can also exhibit similar loss of fluorescence [5,9,10]. While several commercial 
devices have been successfully developed to enhance observation of these autofluorescence 
changes with high sensitivity, the inability to consistently differentiate between benign and 
neoplastic lesions has led to poor adoption [11–15]. 
In an effort to overcome the limitations of COE and autofluorescence imaging, several 
modalities have been explored including nonlinear microscopy [16,17], Raman spectroscopy 
[18,19], fluorescence lifetime imaging (FLIM) [20,21], optical coherence tomography 
[22,23], spectroscopy with point spectrometers [24,25], multispectral imaging [26,27] and 
confocal microscopy [20,28]. While each of these methods delivers valuable information to 
aid in the diagnosis of oral cancer, studies have suggested that a combination of these 
techniques could improve performance [5,7,21,27]. For example, a pilot study with 
multispectral imaging demonstrated the advantages of combining spectral and spatial data 
acquisition over the entire oral cavity [27]. While several point spectroscopy techniques have 
shown high sensitivity and specificity, the sparse spatial sampling of fiber optic probes makes 
it challenging to interrogate the entire surface of the oral cavity [24,25]. Multispectral 
imaging improves upon point spectroscopy by providing both spatial and spectral data. 
However, these systems are still limited because they lack the spatial resolution necessary to 
identify the cellular changes associated with the presence of neoplasia [26,27]. Confocal 
microscopy, a technique employing a spatial filter to improve spatial resolution by providing 
optical sectioning allows for visualization of the cellular changes associated with dysplasia 
[28]. Similar to point spectroscopy, however, confocal devices are usually limited by a small 
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field of view. An ideal system would combine widefield multispectral acquisition capabilities 
with a high resolution imaging technique, allowing for rapid localization of abnormal lesions 
followed by high resolution imaging to determine the presence and degree of neoplasia. 
In this work we present a probe that combines a high resolution confocal microscope with 
widefield multispectral imaging through a single foveated endomicroscope. We previously 
validated the miniature foveated objective by imaging ex vivo mouse colon tissue with a 
confocal microscope [29]. We have now combined the foveated objective with a vibrating 
fiber bundle to relay the image from the objective to both a confocal microscope and an 
image mapping spectrometer (IMS). The IMS is a snapshot spectrometer that is capable of 
acquiring spatial and spectral information at high speed. We previously validated the IMS on 
several tissue models including an in vivo pilot study of normal and cancerous oral tissue 
[27,30,31]. With the combined system, we aim to improve specificity and sensitivity over 
either of the single modalities. In this study, we imaged human ex vivo oral samples, 
providing spectral data to demonstrate the differences between normal and tumor tissue along 
with high resolution imaging in order to image the cellular architecture of the samples. While 
the oral cavity is accessible enough to allow for larger probes than this system to be 
introduced, the advantage of this concept is the co-registration of the two modalities, which 
could eventually prove valuable in smaller, more difficult to reach cavities. The ultimate 
device we envision will utilize the proof of concept presented in this manuscript, consisting of 
a fully enclosed system that will combine the imaging probe with a tool channel for 
dispensing a fluorescent dye and an illumination source. To the best of our knowledge, this is 
the first reported endomicroscope that combines both multispectral fluorescence and high 
resolution confocal fluorescence modalities through a single miniature objective. 
2. Foveated objective 
The complete design, fabrication and performance of the foveated miniature objective were 
reported previously [29]. Briefly, the intentional introduction of distortion into the optical 
design of the objective provides variability in the magnification and numerical aperture across 
the field. With the highest magnification found in the center of the field and demagnification 
towards the edge, it is possible to provide a larger field of view than allowable by the 
Lagrange invariant while maintaining the ability to resolve fine features near the optical axis. 
The lens performs nominally similar to the human eye, in which peripheral vision allows for 
rapid localization of features of interest to then be closer inspected by the fovea of the eye – 
providing higher resolution and more detail. The specific parameters of the miniature 
objective can be found in Table 1, highlighted by the 2.7 mm in diameter objective providing 
a 5 mm field of view with an NA of 0.1 on axis. 
The design consisted of three optical lenses – two PMMA and one Zinc Sulfide lens - to 
provide the majority of the optical power. The prototype lenses were built using single point 
diamond turning on a miniature diamond lathe, utilizing a hypodermic tube as the chassis of 
the objective. The performance of the objective was observed by imaging a 1951 United 
States Air Force resolution target across the entire field by relaying the image from the 
foveated objective to a commercial Zeiss Primostar microscope. The final validation of the 
objective was performed by combining it with a confocal microscope for imaging ex vivo 
mouse colon with colorectal lesions dyed with proflavine [29]. From these images it was 
possible to observe the presence of dysplastic tissue and demonstrate that morphology 
compared well to that observed in histology images. With the foveated objective fully 
validated, the objective required an image relay to the imaging devices that would allow the 
endomicroscope to be used in the body. 
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Table 1. Basic optical parameters of the Foveated Objective. 
Field of View 5 mm 
Diameter of Objective 2.7 mm 
Length of Objective 10 mm 
Image size 1.44 mm 
NA / Magnification on Axis 0.1 / 0.39x 
NA / Magnification at edge of field 0.061 / 0.06x 
Design wavelength 510 nm 
3. Vibrating fiber bundle integration 
In order for the objective to be clinically relevant, an image guide is required to relay the 
image from the objective near the tissue to the imaging devices located away from the 
imaging target. For the foveated objective, which provides an image size of nearly 1.5 mm, 
relaying the complete image without losses is not trivial. Piezoelectric scanners for example 
do not provide a large enough field of view with high enough refresh rates required for in vivo 
imaging. A larger fiber bundle provides an adequate field of view, but the size, pixilation due 
to individual fibers and crosstalk between fibers limits achievable resolution due to 
undersampling. In an effort to improve sampling we present a technique of rapidly vibrating a 
fiber bundle to acquire data that would normally be inaccessible due to the limitations of fiber 
bundle pattern. 
The vibrating fiber bundle setup consists of a miniature electric vibrating motor attached 
to a 60k element, 1.2 mm diameter fiber bundle with a core to core spacing of 4.5 µm 
(Myriad Fiber, Dudley, MA). The vibrating motor (273-0107, Radio Shack, Fort Worth, TV) 
was connected to a voltage driver supplying up to a 3 V signal to provide 16,000 RPM. The 
motor, which is attached to the middle of the fiber, rapidly vibrates the fiber with a maximum 
displacement of approximately ± 50 μm on each end. Initial setup of the vibrating system 
required the adjustment of the clamping pressure of the motor to the fiber bundle and the fine 
tuning of the applied voltage. Once these parameters were set, the system maintained 
alignment. The optical train of the testing system is as follows: Light from a halogen lamp 
passes through a 710 nm filter onto a 1951 USAF negative resolution target. To protect the 
surfaces of the fiber bundle and the resolution target, the image of the target is relayed by two 
4x, 0.1NA Olympus objectives placed back to back (providing 1x magnification) to the fiber 
bundle proximal surface. A CCD camera with a 10x, 0.25NA finite correct objective and a 
tube lens collects the image from the distal end of vibrating fiber bundle. Images were 
collected with voltage applied to the vibrating motor in order to assess the improvement in 
resolution. 
The image below (Fig. 1) displays the resolution target imaged through the fiber bundle 
when voltage is not applied to the motor (A), compared to when voltage is applied and the 
fiber vibrates (B), and without the fiber bundle (C) over the same exposure time. As the 
spatial sampling increases, there is a clear improvement in the resolvability of features when 
comparing the smallest resolvable features for the static fiber bundle (group 6, element 4 
equating to 11.04 µm per line pair) to the resolvable features for the vibrating fiber (group 7, 
element 4 or 5.52 µm per line pair). The limit of resolution for this setup is defined by the 0.1 
NA objectives and the chosen wavelength (710nm), with an ability to resolve features from 
group 7, element 5 (4.33 µm per line pair) according to the Rayleigh criterion for the 
diffraction limit. Thus the system provides nearly diffraction-limited performance when the 
fiber bundle is vibrating, well above the limit of a static fiber bundle, and is appropriate for 
imaging with the foveated objective. 
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 Fig. 1. Image of 1951 USAF neagative resolution target taken through a static fiber bundle (A). 
Image of the same target taken with a vibrating fiber bundle in order to increase the spatial 
sampling, providing an improvement in acievable resolution (B). Image taken with fiber 
bundle removed, showing the limit of resolution of the system without the fiber bundle (C). 
In addition to reducing the visual impact of the fiber bundle pattern, the vibrating method 
minimizes the effects of debris and damage found on the fiber bundle surfaces. This is 
illustrated in the full field images of the resolution target taken through the foveated objective 
(Fig. 2). Figure 2 compares images of the resolution target when the fiber bundle is stationary 
(A) and when vibrating (B), demonstrating the improvement in achievable resolution and 
reduction of defects to the fiber bundle. 
 
Fig. 2. Full field image of 1951 USAF neagative resolution target taken through a static fiber 
bundle and the foveated objective, with red box displaying the higher resolution features and 
green circles indicating defects of the fiber bundle (A). Image of the same target taken with the 
vibrating fiber bundle and foveated obejctive in order to increase the spatial sampling, 
providing an improvement in acievable resolution and overall smoothing of image defects 
from the fiber bundle. The red box displays the higher resolution features while the green 
circles illustrate the reduction in the effects of the defects of the fiber bundle (B). 
4. Confocal and IMS integration with foveated objective 
With sufficient improvement in spatial resolution, the vibrating fiber can be used to integrate 
the foveated objective to the confocal microscope and the Image Mapping Spectrometer, both 
of which have been previously evaluated in several papers. Figure 3 shows a schematic of the 
entire foveated endomicroscope system with the miniature objective, the vibrating fiber 
bundle, the two imaging devices and a computer to display the images in real time. 
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 Fig. 3. Schematic of the completely integrated device with foveated objective on the left 
combined with the vibrating fiber bundle. A beam splitter then splits the signal to the confocal 
microscope and IMS. The images are then displayed on a laptop monitor. 
The next step of integration required a mount to set the distance between the objective and 
the fiber bundle. The proximal end of the objective integratied with the distal end of the fiber 
bundle was accomplished with the 3D printing of a miniature mount to attach the foveated 
objective to the fiber bundle. The mount, designed in Solidworks, increases the outer diameter 
of the probe by 500 µm and relies on friction to hold both the objective and the fiber bundle. 
Three schematics of the mount and an image of the foveated objective in the mount are shown 
in Fig. 4. 
 
Fig. 4. Schematic view of the silver foveated objective, the gray 3D printed mount, and the 
black fiber bundle (A). Cross section view, displaying the lenses within the foveated objective 
and the spacing of the objective to the fiber bundle (B). Photograph of the foveated objective 
held in the mount attached to the fiber bundle (C). Isometric view of the 3D printed holding 
mount (D). 
The custom confocal microscope was reported previously [29]. Briefly, the microscope 
incorporates a 455nm handheld laser pointer, commercial optics, miniature galvanometer 
mirrors, a spatial filter, and a photomultiplier tube to scan and collect a diffraction limited 
point across the region of interest. The spatial filter improves axial resolution over standard 
bright-field imaging by blocking out-of-focus light in the conjugate image plane. A custom 
LABVIEW program drives the mirrors and acquires the images with the ability to control 
scanning speed and amplitude. The beam is focused and scanned on the distal end of the 
optical fiber to collect images. Figure 5 displays an image of lens paper marked with 
fluorescent yellow highlighter and imaged through the fiber bundle alone (A) and through the 
foveated objective with the fiber bundle (B) coupled to the confocal microscope. Due to the 
thickness of the resolution target, confocal images of the resolution target could not be 
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acquired. The addition of the foveated objective increases the field of view from 900 µm to 
1.5 mm diameter, as indicated in Fig. 5. 
 
Fig. 5. Comparison of images of fluorescent lens paper imaged by the confocal microscope 
through a fiber bundle. Images acquired through the bare fiber bundle (A) and through the 
foveated objective coupled to the confocal microscope (B) show an observable increase in 
field of view 
In addition to the high resolution images provided by the confocal microscope, broad 
surveillance of the tissue is accomplished by multispectral imaging with the IMS. The IMS 
has been described previously [32,33] but briefly is a snapshot hyperspectral imaging device, 
which acquires spectral and spatial data simultaneously. The system consists of customized 
optical parts (mirror, lenses and prisms), a bandpass spectral filter (470–670 nm), and a CCD 
camera incorporated into a custom built metal casing. Each image collects greater than 
100,000 spectra across the field - this information can then be used to aid in the localization 
of suspicious lesions. In this setup, the IMS uses external 500 mW white (425–700 nm) and 
670 mW blue (385–425 nm) LEDs to illuminate the tissue directly. As with the confocal 
microscope, the distal end of the vibrating optical fiber is imaged by the IMS to collect the 
widefield images in addition to the spectral information. An image of the USAF resolution 
target through the foveated objective is shown in Fig. 6, along with pseudocolored images at 
8 different wavelengths. 
 
Fig. 6. Full field image of resolution target imaged through the foveated objective by the IMS 
with all wavelengths represented, where the scale bar is equivalent to 500 μm (A). Images of 
the resolution target at eight different wavelengths, pseudocolored to match the represented 
wavelength, where the scale bars are equivalent to 500 μm (B). 
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5. Imaging of ex vivo oral tissue 
To assess the potential of the device to image normal and neoplastic oral tissue, fresh biopsies 
of clinically normal and abnormal oral tissue were imaged with the system immediately 
following removal. Patients gave informed consent and the study was reviewed and approved 
by the IRBs at Rice University and the MD Anderson Cancer Center. Eligible patients were 
those scheduled for surgery to resect abnormal oral cavity tissue. Punch biopsies from the 
lesions and clinically normal sites (when available) were obtained and imaged using the 
foveated endomicroscope. In this study, biospsies were obtained from six patients with 
invasive carcinoma found in the oral cavity. All of the biopsies from the tumors were 
classified between G2 and G4 according to the pathology reports, where G refers to the grade 
of the tumor. A G2 grade of a tumor in the oral cavity indicates moderately differentiated 
cells, while G3 and G4 indicate a very abnormal appearance where the cells are poorly 
differentiated. Utilizing this metric, clinicians can quantify the severity of the cancer. 
First, widefield multispectral images were acquired as the samples were illuminated by 
white and then blue LEDs. The biospsies were then stained by proflavine, a fluorescent dye 
that stains cell nuclei was used as a contrast agent for the confocal imaging. A solution 
containing 0.05% w/v solution of proflavine (Sigma Aldrich, St. Louis, Missouri) in 1X PBS 
was applied topically, the tissue was rinsed with additional PBS, and the biopsies were 
imaged by the high-resolution confocal mode. For testing, the device was secured to an 
optical table, which allowed for external staining of the biopsied sample without moving the 
probe. Figure 7 displays a series of images and the corresponding spectra acquired by the 
foveated endomicroscope of a clinically abnormal biopsy obtained from the maxilla in a 
patient scheduled for total maxillectomy. The pathology report indicated an invasive, 
moderately to poorly differentiated squamous carcinoma. 
 
Fig. 7. Images acquired by the endomicroscope of a biopsy showing invasive oral SCC in 
widefield spectral mode when illuminated by the white and blue LEDs, where the scale bars 
are equivalent to 500 μm. Beneath the images are plots of the associated spectra of these two 
images, which were found by taking the average of the measured spectra of the an area 1 mm 
in diameter at the center of the fields, (indicated by an orange circle). The vertical axis of the 
chart is intensity (arbitrary units) and the horizontal axis is wavelengths (from 460 nm to 660 
nm) (A). Reflectance images of the biopsies at eight different wavelengths, (pseudocolored to 
match the represented wavelengths) showing enhanced viszualitzion of vessels at 548 m, and 
575 nm (areas identified by the red circles), where hemoglobin absorption is maximal - the 
scale bars are equivalent to 500 μm. (B). 
The widefield spectral images shown in Figs. 7(A) and 7(B) show the macroscopic 
structure of the biopsy, while the blue LED allows for observation of the loss of fluorescence 
associated with the lesion before proflavine was applied. Additionally, as shown in Fig. 7(B), 
it is possible to observe vascularization at different depths (red circles) corresponding to the 
wavelength penetration depths (27), which could potentially prove valuable for in vivo 
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samples to distinguish changes in vascularization due to abnormalities. The average spectra 
across the center of the field (Fig. 7(A)) can be used for further analysis. 
An additional metric for spectral analysis consists of comparing the intensity of different 
color channels or at specific wavelengths when the reflectance spectrum is acquired, in order 
to determine relative changes in the spectral response. It has been reported that by analyzing 
the ratio of diffuse reflectance intensity in the oral mucosa at 545 nm and 575 nm, it is 
possible to distinguish between healthy and cancerous oral lesions due to changes in the 
spectra at these wavelengths, which are associated with oxygenated hemoglobin in the tissue 
[34–37]. While a standard RGB camera is unable to differentiate between these two 
wavelengths, the IMS allows for a clear distinction. Analysis of the average 545/575 ratio as 
measured by the device was performed for each biopsy site (Fig. 8). There is a clear trend 
between histologically normal and abnormal biopsies from similar anatomic sites; the ratio is 
lower for normal samples compared to the tumors. The ratios are not uniform between sites, 
most likely due to the different sources of the biopsies in the oral cavity (tongue, maxilla, roof 
of the mouth, buccal, and mandible). For one patient, two biopsied samples from the tumor 
were examined, while for another patient only the tumor was examined and no normal 
samples were collected, as reflected in Fig. 8. 
 
Fig. 8. Scatter plot of the reflectance signal intensity ratio of 545/575 nm from different biopsy 
sites (both normal and from cancerous oral lesions). The error bars represent the standard 
deviation of the average ratios, which were measured in approximately twenty points on each 
biopsy. 
 
Fig. 9. Widefield and confocal mode images of two ex vivo biopsy samples acquired by the 
system (A) A widefield image of a negative for tumor sample from the buccal site. (B) 
confocal image of the same sample treated with proflavine with a red arrow indicating 
individual cell nuclei. (C) Widefield image of biopsy taken from a buccal tumor. (D) Confocal 
image of the biopsy stained with proflavine, illustrating irregular formations, suggesting 
neoplasm. 
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Using the widefield mode with spectral data to locate the suspicious regions of the tissue, 
it is then possible to acquire confocal images at the center of the field of view in order to 
observe morphological changes associated with the development of neoplasia. Biopsies of 
buccal tissue acquired from both a clinically normal and abnormal region of tissue from the 
same patient were imaged by the device in widefield mode (Fig. 9(A) and 9(C)), stained with 
proflavine and then imaged in confocal mode at the center of the field (Fig. 9(B) and 9(D)). 
The confocal images acquired of these samples (Fig. 9(B) and 9(D)), which were 
pseudocolored green to match the proflavine dye, display the differences between the 
negative for tumor and tumor (squamous carcinoma) biopsies as defined in the pathology 
report. Specially, the negative for tumor biopsy was defined as a fragment of tan-yellow 
fibroadipose tissue from the left buccal, while the other biopsy from the right buccal consisted 
of squamous carcinoma that was moderately differentiated. The confocal image of the biopsy 
of negative-for-tumor tissue shown in Fig. 9(B) shows round nuclei of uniform size and shape 
throughout the field of view. In contrast, the confocal image of the abnormal biopsy shown in 
Fig. 9(D) shows extracellular matrix and cellular debris; this is consistent with the pathologic 
diagnosis of moderately differentiated squamous cell carcinoma. 
5. Conclusions 
A multimodal endomicroscope was developed for the rapid localization and identification of 
premalignant and cancerous lesions. This is made possible by a miniature foveated objective 
providing a combination of large field of view with high resolving power on axis. An image 
relay technique to improve spatial resolution was developed for the system by vibrating a 
fiber bundle to improve the spatial sampling, reducing the detrimental visual effects of the 
fiber bundle pattern as well as under-sampling. The objective and fiber bundle were 
integrated with a custom confocal microscope and a custom snapshot imaging spectrometer 
with a 3D printed holder. The device was validated by imaging a 1951 USAF resolution 
target and ex vivo samples of normal and cancerous oral tissue. The successful combination 
of widefield imaging with spectral analysis and high resolution imaging for this pilot study 
suggests this device should be further investigated in clinical studies. Future work will 
involve the testing of larger samples containing normal and abnormal structures in order to 
assess the ability to rapidly differentiate tissues and aid in the demarcation of tumor margins. 
The probe will require further rugidization/packaging for clinical implementation of the 
device, including the introduction of an ergonomic mount that will not affect the vibrating 
fiber bundle. Additionally, the optical probe will be integrated with a tool channel that will 
allow for dispensing of a fluorescent dye and an external illumination source. Eventual in vivo 
studies with additional spectral analysis will further validate the device, as active 
vascularization and effects of palpation during the oral examination can be observed and 
assessed for cancer detecting biomarkers. 
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